Teligent Total Long-Term Assets 2010-2021 | TLGT

Teligent total long-term assets from 2010 to 2021. Total long-term assets can be defined as the sum of all assets classified as non-current
Teligent Annual Total Long-Term Assets
(Millions of US $)
2020 $43
2019 $145
2018 $143
2017 $125
2016 $80
2015 $64
2014 $20
2013 $5
2012 $3
2011 $4
2010 $4
2009 $3
Teligent Quarterly Total Long-Term Assets
(Millions of US $)
2021-06-30 $39
2021-03-31 $40
2020-12-31 $43
2020-09-30 $136
2020-06-30 $136
2020-03-31 $135
2019-12-31 $145
2019-09-30 $145
2019-06-30 $147
2019-03-31 $146
2018-12-31 $143
2018-09-30 $142
2018-06-30 $137
2018-03-31 $134
2017-12-31 $125
2017-09-30 $115
2017-06-30 $101
2017-03-31 $88
2016-12-31 $80
2016-09-30 $80
2016-06-30 $77
2016-03-31 $71
2015-12-31 $64
2015-09-30 $24
2015-06-30 $22
2015-03-31 $21
2014-12-31 $20
2014-09-30 $14
2014-06-30 $5
2014-03-31 $5
2013-12-31 $5
2013-09-30 $5
2013-06-30 $5
2013-03-31 $5
2012-12-31 $3
2012-09-30 $3
2012-06-30 $4
2012-03-31 $4
2011-12-31 $4
2011-09-30 $4
2011-06-30 $4
2011-03-31 $4
2010-12-31 $4
2010-09-30 $3
2010-06-30 $3
2010-03-31 $3
2009-12-31 $3
2009-09-30 $3
2009-06-30 $3
2009-03-31 $4
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.384B 6.36
Dr Reddy's Laboratories (RDY) India $12.329B 23.59
BridgeBio Pharma (BBIO) United States $4.629B 0.00
Bausch Health Cos (BHC) Canada $3.358B 2.43
Amphastar Pharmaceuticals (AMPH) United States $2.294B 13.79
Supernus Pharmaceuticals (SUPN) United States $2.089B 28.44
Taysha Gene Therapies (TSHA) United States $0.490B 79.67
Personalis (PSNL) United States $0.278B 0.00
Assembly Biosciences (ASMB) United States $0.105B 0.00
Sol-Gel Technologies (SLGL) Israel $0.016B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00